185 related articles for article (PubMed ID: 19818350)
1. Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients.
Iyer P; Zekri AR; Hung CW; Schiefelbein E; Ismail K; Hablas A; Seifeldin IA; Soliman AS
Exp Mol Pathol; 2010 Feb; 88(1):107-11. PubMed ID: 19818350
[TBL] [Abstract][Full Text] [Related]
2. Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Dou CY; Fan YC; Cao CJ; Yang Y; Wang K
Dig Dis Sci; 2016 Apr; 61(4):1130-8. PubMed ID: 26660680
[TBL] [Abstract][Full Text] [Related]
3. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
[TBL] [Abstract][Full Text] [Related]
4. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
Yang B; Guo M; Herman JG; Clark DP
Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
[TBL] [Abstract][Full Text] [Related]
6. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
7. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
8. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
[No Abstract] [Full Text] [Related]
9. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.
Teng Y; Fan YC; Mu NN; Zhao J; Sun FK; Wang K
Neoplasma; 2016; 63(3):419-26. PubMed ID: 26925788
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis.
Ramadan RA; Zaki MA; Awad AM; El-Ghalid LA
Genet Test Mol Biomarkers; 2015 Jul; 19(7):399-404. PubMed ID: 26030814
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
Sun S; Li Y; Han S; Jia H; Li X; Li X
BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
[TBL] [Abstract][Full Text] [Related]
12. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients.
Abo El-Khair SM; Elalfy H; Diasty M; Ebrahim EE; Elsamanoudy AZ
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22886. PubMed ID: 34392581
[TBL] [Abstract][Full Text] [Related]
13. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
[TBL] [Abstract][Full Text] [Related]
14. Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma.
Jicai Z; Zongtao Y; Jun L; Haiping L; Jianmin W; Lihua H
Mol Carcinog; 2006 Jul; 45(7):530-6. PubMed ID: 16649250
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
[TBL] [Abstract][Full Text] [Related]
16. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ
Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738
[TBL] [Abstract][Full Text] [Related]
17. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
19. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong IH; Lo YM; Zhang J; Liew CT; Ng MH; Wong N; Lai PB; Lau WY; Hjelm NM; Johnson PJ
Cancer Res; 1999 Jan; 59(1):71-3. PubMed ID: 9892188
[TBL] [Abstract][Full Text] [Related]
20. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
